TORONTO--(Medworxx Solutions Inc. ("Medworxx") (TSX VENTURE: MWX) today announced South Tees Hospitals NHS Foundation Trust as its newest UK client, having licensed the Medworxx Patient Flow solution. They join The Royal Liverpool and Broadgreen University Hospitals NHS Trust who were the first to adopt the Medworxx solution in the UK, and have been recognized with the 2012 EHI award in the category of Outstanding Work in IT-enabled Change in Healthcare.)--
“South Tees recognizes the importance of the Medworxx solution as a concurrent embedded tool that is based upon internationally validated clinical criteria”
Medworxx is working with the specialist, acute, and community teams at South Tees. With over 1000 licensed beds, Medworxx’ Patient Flow solution will cover 100% of the Trust. The software will be implemented in South Tees’ Acute-Care, Virtual Hospital, Rehabilitation and Continuing Care facilities.
“We are encouraged by our growth in the UK which further validates the relevance and strength of our patient flow solution,” says Dan Matlow, President and CEO, Medworxx. “We’ve seen tremendous results with The Royal Liverpool and Broadgreen University Hospitals NHS Trust, and welcome South Tees to our client community, as we work together to standardise admit and discharge decision making for appropriateness of inpatients.” Medworxx Patient Flow helps to reduce Lengths of Stay by identifying barriers and delays to discharge thus enabling appropriate care transitions.
“South Tees recognizes the importance of the Medworxx solution as a concurrent embedded tool that is based upon internationally validated clinical criteria,” says Peter Ellis, UK Managing Director, Medworxx. “The rapid assessment process, ease of use and in-year ROI has led to sustained adoption of the solution as an ‘every patient every day’ patient flow management tool and will contributed to its success in the UK.”
ModelAdvice DC Consulting Ltd UK, a Medworxx UK partner, initially used the Medworxx solution to perform a bed census audit for the Trust. This diagnostic review helped to identify patient flow challenges and barriers and provided a snapshot that demonstrated the potential benefits and ROI and led to South Tees’ decision to implement the Medworxx solution on a concurrent basis.
“We are eager to demonstrate how the benefits to our patients and the use of our resources, indicated in the diagnostic review, can be sustained and built upon through embedding the Medworxx tool as part of our current case management project,” states Sue Watson, Director of Operations at South Tees Hospitals NHS Foundation Trust.
Medworxx Patient Flow, including Medworxx Utilisation Management, Medworxx Bed Board, and Medworxx Assessments provides hospitals with tools to bridge clinical and operational perspectives on daily patient flow – optimal for healthcare systems addressing issues of overcapacity, wait times and care coordination. Spurred onwards by uptake of the patient flow solution in 27,600 acute care beds in Canada and UK’s National Health System (NHS), and a recent launch into the United States, Medworxx is expanding to leverage growth that includes agreements with four of Canada’s 10 Provinces and also includes 2,000 NHS beds in the UK.
About South Tees Hospitals NHS Foundation Trust
South Tees Hospitals NHS Foundation Trust is the largest hospital trust in the Tees Valley. The Trust runs The James Cook University Hospital in Middlesbrough and the Friarage Hospital in Northallerton. It also runs community services in Hambleton and Richmondshire, Middlesbrough and Redcar and Cleveland.
Its workforce of almost 9,000 provides a range of specialist regional services to 1.5million people in the Tees Valley and parts of Durham, North Yorkshire and Cumbria, with a particular expertise in heart disease, trauma, neurosciences, renal services, cancer services and spinal injuries
Medworxx delivers health information technology solutions to over 350 hospitals internationally; including Canada, United States and United Kingdom. Medworxx helps hospitals meet patient flow challenges, and requirements in compliance and education. Medworxx Utilisation Management—flagship of Medworxx Patient Flow that includes electronic bed board and independent assessment components—currently serves 33%of the acute care beds in Canada.
Synergies in the Canadian and UK health systems led ModelAdvice DC Consulting and Medworxx to collaborate in addressing the UK market, with a focus on NHS Trust hospitals. Model Advice DC methodology for approaching vertical health system integration combines with Medworxx Patient Flow tools to harvest data and intelligence, to model hospitals’ patient flow needs and future requirements. Founded in 2004, Medworxx Inc. is based in Toronto, ON, and publicly traded on the TSX Venture Exchange: MWX
The statements made in this press release may contain forward-looking statements that may involve a number of risks and uncertainties. Actual events or results could differ materially from the company’s expectations and projections. The TSX Venture Exchange has not reviewed this press release and neither approved nor disapproved the information contained in this press release.